The Columbus Dispatch reported yesterday that an Ohio jury had decided against the ACS for $27 million in a dispute with the founders of Leadscope, Inc. The case was a countersuit by Leadscope, who alleged that Chemical Abstracts Service (CAS) had damaged their company in pursuing an earlier lawsuit.